PET CT
PET-CT Scan: The Power of Precision in Diagnostic Imaging
Leading the Way in Oncology and Advanced Diagnostics in North Bengal
Anandaloke Sonoscan Centre is proud to offer state-of-the-art Positron Emission Tomography–Computed Tomography (PET-CT) imaging, including technology like PET CT with TOF (Time-of-Flight). This advanced hybrid imaging modality is a crucial tool in modern medicine, providing unparalleled detail by merging the functional information from PET with the precise anatomical detail from CT.
For patients and referring physicians across North Bengal, Sikkim, Bhutan, and Nepal, we deliver world-class diagnostic clarity right here in Siliguri.
What is PET-CT and Why is it Essential?
PET-CT is a game-changer, particularly in the field of oncology. While a conventional CT scan shows the structure of tissues, the PET component shows their metabolic activity. By fusing these images, we can accurately pinpoint disease, often long before structural changes become visible.
Key Applications of PET-CT
- Cancer Diagnosis: Identifying and characterizing tumors with high accuracy.
- Cancer Staging: Precisely determining the extent of the disease and checking for metastasis (spread from an unknown primary site).
- Restaging & Follow-up: Monitoring for recurrence in patients after treatment, and long-term surveillance.
- Treatment Evaluation: Assessing the effectiveness of chemotherapy and radiation therapy by tracking changes in tumor metabolism.
- Biopsy Site Determination: Identifying the metabolically most active part of a tumor to guide highly accurate biopsies.
- Differentiating Tumors: Helping to distinguish between benign (non-cancerous) and malignant (cancerous) lesions.
- Specialized Radiotracers: We offer advanced studies using specific radiotracers, including:
- 18-F-FDG PET: The most common tracer, used to assess glucose metabolism in most cancers.
- 68-Gallium-DOTA PET: Used for Neuroendocrine Tumours and Medullary Carcinoma of the Thyroid.
- 68-Gallium/18 Fluorine-PSMA PET: Essential for highly specific evaluation of Metastatic Prostate Cancer.